ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019

Go back to ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019

ResMed (RMD) Tops Q1 EPS by 2c, Revenues Beat

October 25, 2018 4:14 PM EDT

ResMed (NYSE: RMD) reported Q1 EPS of $0.81, $0.02 better than the analyst estimate of $0.79. Revenue for the quarter came in at $588.3 million versus the consensus estimate of $571.29 million.

Revenue increased 12% to $588.3 million; up 13% on a constant currency basisNet income increased by 23%;... More